Symmetry Partners, LLC Moderna, Inc. Transaction History

Symmetry Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 02, 2024	SELL	$69.51 - $104.43 $44,277 - $66,521	-637 Reduced 15.5%	3,474 $343,000
Q3 2023 Oct 10, 2023	SELL	$96.41 - $126.61 $95,156 - $124,964	-987 Reduced 19.36%	4,111 $425,000
Q2 2023 Jul 05, 2023	SELL	$118.5 - $160.53 $281,556 - $381,419	-2,376 Reduced 31.79%	5,098 $619,000
Q1 2023 Apr 03, 2023	BUY	$135.66 - $197.02 $103,101 - $149,735	760 Added 11.32%	7,474 $1.15 Million
Q3 2022 Oct 03, 2022	BUY	$118.07 - $194.18 $313,357 - $515,353	2,654 Added 65.37%	6,714 $794,000
Q2 2022 Jul 11, 2022	SELL	$117.13 - $176.59 $483,161 - $728,433	-4,125 Reduced 50.4%	4,060 $580,000
Q1 2022 Apr 04, 2022	SELL	$126.46 - $235.05 $160,098 - $297,573	-1,266 Reduced 13.4%	8,185 $1.41 Million
Q4 2021 Jan 11, 2022	BUY	$225.82 - $368.51 $63,229 - $103,182	280 Added 3.05%	9,451 $2.4 Million
Q2 2021 Jul 07, 2021	BUY	$129.91 - $234.98 $824,928 - $1.49 Million	6,350 Added 225.1%	9,171 $2.16 Million
Q1 2021 May 03, 2021	SELL	$109.18 - $185.98 $22,927 - $39,055	-210 Reduced 6.93%	2,821 $369,000
Q4 2020 Feb 18, 2021	BUY	$65.74 - $169.86 $199,257 - $514,845	3,031 New	3,031 $317,000

1,045

242M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $21.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.